CASI Pharmaceuticals Inc (NASDAQ:CASI)

6.85
Delayed Data
As of Apr 20
 -0.04 / -0.58%
Today’s Change
0.91
Today|||52-Week Range
7.59
+110.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues23.7K47.7K0.000.00
 
 
 
Cost of Goods Sold7.5K6.3K0.000.00
 
 
 
Depreciation And Amortization48.2K68.4K66.5K117.8K
 
 
 
 
 
 
Operating ExpensesGross Income-31.9K-26.9K-66.5K-117.8K
 
 
 
 
 
General Expenses6.5M7.1M9.4M10.6M
 
 
 
 
 
Research And Development2.8M4.1M4.6M7.6M
 
 
 
 
 
Total Operating Expenses6.5M7.2M9.4M10.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.5M-7.2M-9.4M-10.8M
 
 
 
 
 
Extraordinary Credit11.8K27.5K0.000.00
 
 
 
Extraordinary Charge-19.7M0.00-6.8K-19.9K
 
 
 
 
Interest Expense On Debt28.1K82.5K33.8K15.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.2M-7.2M-9.5M-10.8M
 
 
 
 
 
Net Income-26.2M-7.2M-9.5M-10.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.6M32.4M55.9M61.5M
 
 
 
 
 
Shares To Calculate EPS Diluted28.6M32.4M55.9M61.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.92-$0.22-$0.17-$0.18
 
 
 
 
 
EPS Diluted-$0.92-$0.22-$0.17-$0.18